Ecovyst Reports Third Quarter 2026 Results and Raises 2026 Outlook

Ecovyst posts strong Q3 growth, raises 2026 guidance, but leverage rises after Calabrian deal.

What the company is saying

Ecovyst emphasizes a robust third quarter, highlighting a 51% year-over-year sales increase to $308.6 million and net income of $18.4 million, up from $0.2 million. CEO Kurt J. Bitting attributes growth to strong refining margins, export demand, and increased sales of regenerated and virgin sulfuric acid, with the first full quarter of Calabrian contributing as expected. The company raises full-year 2026 guidance for Adjusted EBITDA to $208–$212 million, sales to $1,050–$1,070 million, and Adjusted Free Cash Flow to $50–$60 million, citing momentum and the Calabrian acquisition. Ecovyst frames its capital allocation as flexible, balancing organic and inorganic growth with shareholder returns, and notes $2.7 million in Q3 share repurchases with an intent to reach $20 million in H2 2026. The narrative is confident, focusing on operational execution, integration progress, and healthy end-market demand, while acknowledging potential risks from refinery outages and sulfur price volatility.

What the data suggests

The reported figures show clear operational and financial improvement: Q3 2026 sales from continuing operations rose to $308.6 million, up $103.7 million or 51% from Q3 2025. Net income increased to $18.4 million from $0.2 million, and Adjusted EBITDA grew 6% to $61.2 million. Adjusted Net Income reached $25.3 million, up from $21.5 million. Cash flow from operating activities for the first nine months was $80.7 million, up from $77.0 million, though Adjusted Free Cash Flow declined to $32.4 million from $42.4 million. The Calabrian acquisition added $100 million in term debt, raising gross debt to $497.1 million and the Net Debt Leverage Ratio to 2.1x from 1.2x at year-end 2025. Liquidity remains solid at $167.0 million. Share repurchases totaled $2.7 million in Q3, with $143.8 million still authorized. Raised full-year guidance reflects confidence but depends on continued strong demand and successful integration. The company’s sales outlook assumes a $220 million sulfur cost pass-through, but actual sulfur price sensitivity and demand forecasts are not quantified. The evidence supports recent financial gains, but forward projections rely on market and integration assumptions.

Analysis

The announcement presents a positive tone, supported by strong realised financial results: sales from continuing operations rose 51% year-over-year, net income increased sharply, and Adjusted EBITDA grew by 6%. These improvements are clearly evidenced by disclosed figures. However, a significant portion of the release is forward-looking, including raised full-year guidance, expectations for market demand, and intentions for further share repurchases. The company highlights a $100 million term loan increase for the Calabrian acquisition and capital expenditures of $90–95 million, indicating high capital intensity, but the benefits from these investments are expected within the current year, not long-term. Some operational outlooks (sulfur prices, demand for sulfuric acid, mining activity) are stated without quantitative support, and the pass-through of sulfur costs is an assumption rather than a realised fact. While the realised financial progress is genuine, the narrative inflates the outlook by projecting continued strong demand and successful integration without providing detailed evidence for these projections.

Risk flags

• ●Leverage has increased following the Calabrian acquisition, with Net Debt Leverage Ratio rising to 2.1x from 1.2x at year-end 2025. This higher debt load raises financial risk if integration or market conditions deteriorate.
• ●Forward guidance depends on continued strong demand for sulfuric acid and stable refinery utilization. Any unplanned refinery outages or a sharp decline in sulfur prices could negatively impact sales and margins, as acknowledged by management.
• ●Synergy realization from the Calabrian acquisition is assumed but not yet demonstrated with quantified results. If integration fails to deliver expected benefits, profitability could fall short of guidance.
• ●Adjusted Free Cash Flow has declined year-over-year despite higher earnings, indicating potential pressure from capital expenditures or working capital needs. Sustained cash generation will be critical to support debt service and shareholder returns.
• ●The company’s sales outlook is based on a projected $220 million sulfur cost pass-through, but lacks detailed sensitivity analysis. Unexpected sulfur price movements could materially affect results.

Bottom line

Ecovyst delivered a strong Q3, with sales up 51% and net income rebounding sharply, driven by higher sulfuric acid demand and the Calabrian acquisition. The company is confident enough to raise 2026 guidance across all major metrics, but this optimism is partly based on assumptions about continued market strength and successful integration. Leverage has increased, and free cash flow is down year-over-year, highlighting the need for disciplined execution. The raised guidance and ongoing share buybacks are positive, but investors should watch for evidence of synergy capture and resilience if sulfur prices or refinery demand weaken. The most important takeaway: Ecovyst’s growth story is real, but its higher debt and reliance on favorable market conditions mean execution and market risks remain front and center.

Announcement summary

(NYSE: ECVT) Ecovyst Inc. reported third quarter 2026 results, reflecting the inclusion of the Calabrian sulfur dioxide and related derivatives business acquired on June 30, 2026, and the exclusion of the divested Advanced Materials & Catalysts business, which is now reported in discontinued operations. Third quarter 2026 sales from continuing operations grew 51% to $308.6 million, an increase of $103.7 million from $204.9 million in the third quarter of 2025. Net income for the quarter was $18.4 million, up from $0.2 million in the prior year, with a net income margin of 6.0% and diluted net income per share of $0.17. Adjusted Net Income was $25.3 million, compared to $21.5 million in the year-ago quarter, and Adjusted Diluted Income per share was $0.23. Adjusted EBITDA was $61.2 million, an increase of $3.7 million or 6% compared to $57.5 million in the third quarter of 2025. Cash flow from operating activities for the nine months ended September 30, 2026 was $80.7 million, compared to $77.0 million for the same period in 2025. Adjusted Free Cash Flow for the nine months ended September 30, 2026 was $32.4 million, compared to $42.4 million in the prior year period. As of September 30, 2026, cash and cash equivalents were $71.2 million, total gross debt was $497.1 million, and availability under the Asset-Based Lending facility was $95.8 million, after $2.2 million of outstanding letters of credit, resulting in total available liquidity of $167.0 million. The Net Debt to Net Income Ratio was 9.7x and the Net Debt Leverage Ratio was 2.1x, up from 1.2x at December 31, 2025, due to a $100 million increase in the term loan for the Calabrian acquisition. The company repurchased $2.7 million of its common stock in the third quarter of 2026 and intends to repurchase up to a total of $20 million in the second half of 2026. As of September 30, 2026, $143.8 million remained available for stock repurchases under the program. During the third quarter of 2026, 263,719 shares were repurchased at an average price of $10.25 per share. The company raised its full-year 2026 Adjusted EBITDA guidance to a range of $208 million to $212 million, sales guidance to $1,050 million to $1,070 million, Adjusted Free Cash Flow guidance to $50 million to $60 million, capital expenditures to $90 million to $95 million, interest expense to $19 million to $21 million, depreciation & amortization to $84 million to $88 million, and Adjusted Net Income to $70 million to $85 million with Adjusted Diluted Income per share of $0.63 to $0.77. The sales outlook assumes higher average sulfur prices and a higher projected pass-through of sulfur costs of approximately $220 million. The company expects demand for regenerated and virgin sulfuric acid to remain positive for the remainder of 2026, with high refinery utilization and strong alkylate demand supporting regenerated sulfuric acid sales, and ongoing growth in copper mining applications benefiting virgin sulfuric acid sales. For the Calabrian business, high operating rates for Canadian gold mines are expected to continue in the fourth quarter. The company remains flexible in capital allocation, pursuing both organic and inorganic growth opportunities and returning capital to stockholders through share repurchases.

Disagree with this article?